Dual Monoclonal Antibody Therapy for a Severe Asthma Patient

• Main Authors: Christian Domingo (Author), Xavier Pomares (Author), Anisi Morón (Author), Ana Sogo (Author)
• 格式: 圖書
• 出版: Frontiers Media S.A., 2020-09-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

IntroductionOmalizumab, the first biological treatment for severe allergic bronchial asthma, has been on the market for more than a decade. Omalizumab was initially considered to be an IgE-blocking agent, and therefore, an inhibitor of the Th2 (allergic or adaptive) cascade. More recently, other mon...